Recover Affiliate Password

	XML/RSS New Company Feed

	Npros News Blog

	Click here to receive News Updates via email.

Regeneca Issues a Voluntary Recall of RegenArouse
February 10, 2012 - Regeneca, Inc. announced today that it is conducting a voluntary nationwide recall of RegenArouse, Lot Number 130100, because FDA lab analysis has confirmed the presence of Tadalafil making these products unapproved new drugs. Tadalafil is an FDA-approved drug used as treatment for male Erectile Dysfunction (ED). The active drug ingredient is not listed on the label for these products.
LifeVantage Spokesperson Donny Osmond Appears on Dr Phil Show
Liberty Health Network Announces Record Revenue Increase
Ignite to Unveil Expansion Plans at Annual Convention
Dr Mehmet Oz Signs on as Keynote Speaker for Vemma Convention

Password Recovery

Your Email Address
Your password will be emailed to the address provided. Please be sure to check your spam filters to allow email from Npros.com